Skip to main content
Premium Trial:

Request an Annual Quote

NCI’s Cancer Research Center Will Use BioFortis' Labmatrix Software

NEW YORK (GenomeWeb News) - BioFortis today said that the National Cancer Institute selected its Labmatrix software for use within the Center for Cancer Research.

 
CCR evaluated the software within the Neuro Oncology Branch.
 
Labmatrix is a web-based, enterprise translational research information-management software platform. It integrates clinical data with genomic, proteomic, and laboratory experimental data, and maintains annotated tissue banks.
 
The National Institutes of Health collaborated with BioFortis in developing Labmatrix.
 
CCR is composed of multiple labs, branches, and core facilities supporting both clinical and basic sciences, with a focus on translational cancer research.

Filed under

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.